Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 13, 2015 10:36 PM ET


Company Overview of CareDx, Inc

Company Overview

CareDx, Inc, a commercial stage company, develops, markets, and delivers diagnostic surveillance solutions for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient’s lifetime. Its commercialized testing solution includes the AlloMap heart transplant molecular test (AlloMap), a blood-based test used to monitor heart transplant recipients for acute cellular rejection. The company markets its AlloMap solution to healthcare providers through its direct sales force that targets transplant centers and their physicians, coordinators, and nurse practitioners in the United States, Canada, and Europe. The company was formerly known as XDx...

3260 Bayshore Boulevard

Brisbane, CA 94005

United States

Founded in 1998

68 Employees





Key Executives for CareDx, Inc

Chief Executive Officer, President and Director
Age: 48
Total Annual Compensation: $547.6K
Chief Medical Officer and Executive Vice President
Age: 66
Total Annual Compensation: $524.5K
Chief Compliance Officer and Chief Business Officer
Age: 45
Total Annual Compensation: $445.5K
Compensation as of Fiscal Year 2014.

CareDx, Inc Key Developments

CareDx, Inc Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended March 31, 2015; Confirms Revenue Guidance for the Year 2015

CareDx Inc. reported unaudited earnings results for the second quarter and six months ended March 31, 2015. For the quarter, the company reported total revenues of USD 7.129 million compared to USD 6.776 million a year ago. Loss from operations was USD 2.886 million compared to USD 0.345 million a year ago. Loss before income taxes was USD 3.185 million compared to USD 0.623 million a year ago. Net loss was USD 3.185 million compared to net income of USD 0.877 million a year ago. Diluted loss per share was USD 0.27 compared to earnings per share of USD 0.13 a year ago. For the six months, the company reported total revenues of USD 14.344 million compared to USD 12.700 million a year ago. Loss from operations was USD 4.277 million compared to USD 0.572 million a year ago. Loss before income taxes was USD 5.457 million compared to USD 1.927 million a year ago. Net loss was USD 5.457 million compared to USD 0.427 million a year ago. Diluted loss per share was USD 0.46 compared to USD 0.42 a year ago. The company confirmed revenue for the full year of 2015 is expected to be in the range of USD 28 to USD 30 million.

CareDx Seeks Acquisitions

CareDx, Inc (NasdaqGM:CDNA) has filed a Shelf Registration in the amount of $75 million. CareDx will use the net proceeds from the sale of securities offered by this prospectus for general corporate purposes, which may include working capital, capital expenditures, other corporate expenses and acquisitions of complementary products, technologies or businesses.

CareDx, Inc to Report Q2, 2015 Results on Aug 10, 2015

CareDx, Inc announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Aug 10, 2015

Similar Private Companies By Industry

Company Name Region
MitoPharm Corporation United States
Finnzymes, Inc. United States
Interfacial Dynamics Corporation United States
Reaction Biology Corporation United States
Urology Diagnostics, Inc. United States

Recent Private Companies Transactions

Private Placement
January 30, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CareDx, Inc, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at